Your browser doesn't support javascript.
loading
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer.
Corbaux, Pauline; Colomban, Olivier; Carrot, Aurore; You, Benoit.
Affiliation
  • Corbaux P; EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Oullins-Pierre-Bénite, 69921, France.
  • Colomban O; Medical Oncology, Institut de Cancérologie et d'Hématologie Universitaire de Saint-Étienne (ICHUSE), Centre Hospitalier Universitaire de Saint-Etienne, Saint-Priest-en-Jarez, 42270, France.
  • Carrot A; EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Oullins-Pierre-Bénite, 69921, France.
  • You B; EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Oullins-Pierre-Bénite, 69921, France.
Biomark Med ; 18(10-12): 509-510, 2024.
Article in En | MEDLINE | ID: mdl-38884128
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Drug Resistance, Neoplasm / Neoplasm Recurrence, Local Limits: Female / Humans / Middle aged Language: En Journal: Biomark Med Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Drug Resistance, Neoplasm / Neoplasm Recurrence, Local Limits: Female / Humans / Middle aged Language: En Journal: Biomark Med Year: 2024 Document type: Article